Cargando…

An Autoimmune Myositis-Overlap Syndrome Associated With Autoantibodies to Nuclear Pore Complexes: Description and Long-Term Follow-up of the Anti-Nup Syndrome

Autoimmune myositis encompasses various myositis-overlap syndromes, each being identified by the presence of serum marker autoantibodies. We describe a novel myositis-overlap syndrome in 4 patients characterized by the presence of a unique immunologic marker, autoantibodies to nuclear pore complexes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senécal, Jean-Luc, Isabelle, Catherine, Fritzler, Marvin J., Targoff, Ira N., Goldstein, Rose, Gagné, Michel, Raynauld, Jean-Pierre, Joyal, France, Troyanov, Yves, Dabauvalle, Marie-Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602431/ https://www.ncbi.nlm.nih.gov/pubmed/25500708 http://dx.doi.org/10.1097/MD.0000000000000223

Ejemplares similares

Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes
por: Koenig, Martial, et al.
Publicado: (2007)

Redefining Dermatomyositis: A Description of New Diagnostic Criteria That Differentiate Pure Dermatomyositis From Overlap Myositis With Dermatomyositis Features
por: Troyanov, Yves, et al.
Publicado: (2014)

Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype
por: Troyanov, Yves, et al.
Publicado: (2017)

Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies
por: Landon-Cardinal, Océane, et al.
Publicado: (2020)

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013)

Myositis with prominent B-cell aggregates causing shrinking lung syndrome in systemic lupus erythematosus: a case report
por: Roy, Flavie, et al.
Publicado: (2022)

Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome
por: Mathis, Stéphane, et al.
Publicado: (2016)

Ipilimumab/nivolumab: Myocarditis-myositis overlap syndrome and ocular myositis: case report
Publicado: (2020)

Mutations in nuclear pore genes NUP93, NUP205, and XPO5 cause steroid resistant nephrotic syndrome
por: Braun, Daniela A., et al.
Publicado: (2016)

Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS)
por: Nguyen, Henry H., et al.
Publicado: (2018)

Systemic lupus erythematosus-myositis overlap syndrome with lupus nephritis
por: Dey, Biswajit, et al.
Publicado: (2020)

Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
por: Amlani, Adam, et al.
Publicado: (2019)

Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype
por: El Kamouni, Hajar, et al.
Publicado: (2023)

Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome
por: Sloupenska, Kristyna, et al.
Publicado: (2023)

The nucleoporins Nup170p and Nup157p are essential for nuclear pore complex assembly
por: Makio, Tadashi, et al.
Publicado: (2009)

Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome
por: Mahler, Michael, et al.
Publicado: (2022)

Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis
por: Giannini, Margherita, et al.
Publicado: (2023)

Myositis autoantibodies and clinical phenotypes
por: Ghirardello, Anna, et al.
Publicado: (2014)

Anti–Valosin‐Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies
por: Amlani, Adam, et al.
Publicado: (2022)

Analysis of myositis autoantibodies in Chinese patients with cancer‐associated myositis
por: Li, Liubing, et al.
Publicado: (2020)

Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023)

Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)

Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease
por: Mammen, Andrew L., et al.
Publicado: (2015)

Nup84, A Novel Nucleoporin That Is Associated With CAN/Nup214 on the Cytoplasmic Face of the Nuclear Pore Complex
por: Bastos, Ricardo, et al.
Publicado: (1997)

Bench to bedside review of myositis autoantibodies
por: Palterer, Boaz, et al.
Publicado: (2018)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

Isolated anti-Ku antibody in scleroderma-myositis overlap syndrome: the histo-pathological patern
por: Azanmene, Bernard, et al.
Publicado: (2012)

The use and abuse of commercial kits used to detect autoantibodies
por: Fritzler, Marvin J, et al.
Publicado: (2003)

Nuclear Distributions of NUP62 and NUP214 Suggest Architectural Diversity and Spatial Patterning among Nuclear Pore Complexes
por: Kinoshita, Yayoi, et al.
Publicado: (2012)

Molecular architecture of the Nup84–Nup145C–Sec13 edge element in the nuclear pore complex lattice
por: Brohawn, Stephen G., et al.
Publicado: (2009)

Insights into the role of Nup62 and Nup93 in assembling cytoplasmic ring and central transport channel of the nuclear pore complex
por: Madheshiya, Pankaj K., et al.
Publicado: (2022)

Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent
por: Fritzler, Marvin J.
Publicado: (2012)

Prevalence of Myositis-Specific Autoantibodies and Myositis-Associated Autoantibodies in COVID-19 Patients: A Pilot Study and Literature Review
por: Swartzman, Isaac, et al.
Publicado: (2022)

Specific Binding of the Karyopherin Kap121p to a Subunit of the Nuclear Pore Complex Containing Nup53p, Nup59p, and Nup170p
por: Marelli, Marcello, et al.
Publicado: (1998)

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity
por: Tansley, Sarah L, et al.
Publicado: (2020)

The changing landscape of the clinical value of the PM/Scl autoantibody system
por: Mahler, Michael, et al.
Publicado: (2009)

Myositis-specific autoantibodies: detection and clinical associations
por: van Dooren, Sander H. J., et al.
Publicado: (2011)

Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis
por: García-De La Torre, Ignacio
Publicado: (2015)

Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020)

Myositis Specific Autoantibodies: A Clinical Perspective
por: Alenzi, Fahidah M
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k13s40mnh86b88o5nv68a92qgm